ES2135384T3 - Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos. - Google Patents

Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos.

Info

Publication number
ES2135384T3
ES2135384T3 ES91120474T ES91120474T ES2135384T3 ES 2135384 T3 ES2135384 T3 ES 2135384T3 ES 91120474 T ES91120474 T ES 91120474T ES 91120474 T ES91120474 T ES 91120474T ES 2135384 T3 ES2135384 T3 ES 2135384T3
Authority
ES
Spain
Prior art keywords
derivatives
optically active
dihydropyridine
produce
procedures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91120474T
Other languages
English (en)
Inventor
Hiroshi Ikawa
Akiyoshi Kadoiri
Yasuko Konagai
Tetsuaki Yamaura
Noriko Kase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Application granted granted Critical
Publication of ES2135384T3 publication Critical patent/ES2135384T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE EXPONEN LOS DERIVADOS DE 1,4-DIHIDROPIRIDINA Y DERIVADOS OPTICAMENTE ACTIVOS DE LA MISMA, CON LA FORMULA SIGUIENTE PROVISTOS DE ACTIVIDAD VASODILATADORA BASADA EN EL ANTAGONISMO DEL CALCIO Y DEL PAF, Y METODOS PARA PRODUCIRLOS: DONDE (*) INDICA UN CENTRO QUIRAL EN EL CASO DE LOS DERIVADOS DE 1,4-DIHIDROPIRIDINA OPTICAMENTE ACTIVOS.
ES91120474T 1990-11-30 1991-11-29 Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos. Expired - Lifetime ES2135384T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33000590 1990-11-30
JP20728391 1991-07-25
JP20728491 1991-07-25

Publications (1)

Publication Number Publication Date
ES2135384T3 true ES2135384T3 (es) 1999-11-01

Family

ID=27328739

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91120474T Expired - Lifetime ES2135384T3 (es) 1990-11-30 1991-11-29 Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos.

Country Status (10)

Country Link
US (3) US5367081A (es)
EP (1) EP0488345B1 (es)
JP (1) JP3100444B2 (es)
KR (1) KR940005016B1 (es)
AT (1) ATE182140T1 (es)
CA (2) CA2056799C (es)
DE (1) DE69131444T2 (es)
DK (1) DK0488345T3 (es)
ES (1) ES2135384T3 (es)
GR (1) GR3031294T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9819860D0 (en) 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
WO2000078720A1 (en) * 1999-06-23 2000-12-28 Ajinomoto Co., Inc. Novel dihydropyridine derivative
WO2005016885A2 (en) * 2003-08-14 2005-02-24 Artesian Therapeutics, Inc. COMPOUNDS WITH COMBINED CALCIUM CHANNEL BLOCKER AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITIES FOR TREATMENT OF HEART DISEASE
CN104860873A (zh) * 2015-05-28 2015-08-26 石家庄学院 一种(s)-1,4-二氢吡啶钙离子拮抗剂的制备方法
EP4252843A4 (en) * 2020-11-30 2025-02-19 Kyushu University, National University Corporation Compound having inhibitory action against excessive mitochondrial divisions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145956A1 (de) * 1983-11-16 1985-06-26 Ciba-Geigy Ag Neue Amid-Verbindungen
US4616002A (en) * 1984-11-09 1986-10-07 Ciba-Geigy Corporation Dihydro pyridine compounds, compositions and use
GB8503424D0 (en) * 1985-02-11 1985-03-13 Ici Plc Heterocyclic derivatives
CA1341262C (en) * 1987-08-06 2001-06-26 Camille A. Boulet A new process of the synthesis of 3',4'-anhydrovinblastine, vinblastine and vincristine
US5276150A (en) * 1989-05-31 1994-01-04 Fujirebio Inc. 1,4-dihydropyridine derivatives

Also Published As

Publication number Publication date
CA2350854C (en) 2005-01-04
US5859244A (en) 1999-01-12
CA2350854A1 (en) 1992-05-31
US5763614A (en) 1998-06-09
DK0488345T3 (da) 2000-01-24
KR940005016B1 (ko) 1994-06-09
JP3100444B2 (ja) 2000-10-16
EP0488345B1 (en) 1999-07-14
JPH0578319A (ja) 1993-03-30
EP0488345A1 (en) 1992-06-03
DE69131444D1 (de) 1999-08-19
CA2056799C (en) 2002-01-01
US5367081A (en) 1994-11-22
CA2056799A1 (en) 1992-05-31
GR3031294T3 (en) 1999-12-31
DE69131444T2 (de) 1999-12-23
ATE182140T1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
ES2017611T3 (es) Tiazoles sustituidos y su uso como fungicidas.
ES2141559T3 (es) Derivados de 2-ciano-1-sulfonamidofenil-1,3-diona y su uso como herbicidas.
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
ES2084702T3 (es) Imidazoles sustituidos utiles como inhibidores de la angiotensina ii.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
BG33153A3 (bg) Метод за получаване на 1-арилокси-2-хидрокси-3-алкиленаминопропани
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
ES2056071T3 (es) Triazolinonas substituidas.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2066808T3 (es) Derivados de quinoleina, su produccion y uso.
ES2117123T3 (es) Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina.
ES2048109B1 (es) Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
ES2040231T3 (es) Composiciones medicamentosas estables.
ES2134777T3 (es) Nuevos compuestos de sulfonilo.
ES2062215T3 (es) Derivados aminoalcoxibencenicos sustituidos.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2168276T3 (es) 1-arilsulfonil-3-fenil-1,4,5,6-tetrahidropiridazinas.
FI851261A0 (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES8604922A1 (es) Procedimiento para la preparacion de n-piridilindoles
ES2039040T3 (es) Paramentos para movimientos de tierra.
ES2062202T3 (es) Derivado del indol.
BE869734A (fr) Chaine d'amplification laser
ES2135384T3 (es) Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 488345

Country of ref document: ES